Pluristem Therapeutics Inc (PSTI)

[zzaatt]

While again this is nice PR, I still don't see much return for PSTI on this.

Totally disagree with that:

1. Going from a new and exotic and promising technology is huge in terms of the investor recognition and PPS. It's going from theoretical to actual.

2. No danger of running out of patients (unfortunately). Given the severity of the disease, the worldwide impact, having an effective therapeutic tool to mitigate the course of the disease is huge, for patient and Pluristem.

3. While CLI is important, and sufficient by itself for a huge success for the company, good outcome with Covid would be explosive in terms of the pps immediately.

I don't know what Spidey means by "much return", but we just saw is a doubling of the value of Pluristem based on very early results. More convincing results will "double" the PPS many times over.